Evan Chen

17PUBLICATIONS
124CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine.

|Feb 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Jan 26, 2026
Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Luis E Aguirre, Haesook T Kim, Hany Elmariah

|Jan 23, 2026
Challenges and Solutions to Implementation of Chimeric Antigen Receptor Therapies in Acute Myeloid Leukemia.

Shivahamy Maheswaran, Caroline D Gordon, Evan C Chen

|Jan 13, 2026
More than CLK bait? Rogocekib for MDS and AML.

Evan C Chen, Maximilian Stahl

Pageof 3

Frequent Collaborators

10 joint publications

Marlise R Luskin

6 joint publications

Jacqueline S Garcia

5 joint publications

Lori S Muffly

5 joint publications

Shai Shimony